Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: Identification of the prairie epidemic strain

Journal of Clinical Microbiology

Volumn 52, Issue 4, 2014, Pages 1127-1135

  Parkins, Michael D ^a   Glezerson, Bryan A ^a   Sibley, Christopher D ^a   Sibley, Kristen A ^a   Duong, Jessica ^a   Purighalla, Swathi ^a   Mody, Christopher H ^a   Workentine, Matthew L ^b   Storey, Douglas G ^a   Surette, Michael G ^a,b   Rabin, Harvey R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; TOBRAMYCIN; BACTERIAL DNA;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BRONCHIECTASIS; CANADA; CLONE; CONTROLLED STUDY; CYSTIC FIBROSIS; EPIDEMIC; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PULSED FIELD GEL ELECTROPHORESIS; SPUTUM ANALYSIS; TRANSITION TO ADULT CARE; CLASSIFICATION; CLUSTER ANALYSIS; COMPLICATION; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; PSEUDOMONAS INFECTIONS;

ADULT; CLUSTER ANALYSIS; CYSTIC FIBROSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMICS; GENOTYPE; HUMANS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84897146642     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03218-13     Document Type: Article

References (55)

1. Emerson J, McNamara S, Buccat AM, Worrell K, Burns JL. 2010. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008. Pediatr. Pulmonol. 45:363-370. http://dx.doi.org/10.1002/ppul.21198.
2. Lambiase A, Raia V, Del Pezzo M, Sepe A, Carnovale V, Rossano F. 2006. Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect. Dis. 6:4. http://dx.doi.org/10.1186/1471-2334-6-4.
3. Razvi S, Quittell L, Sewall A, Quinton H, Marshall B, Saiman L. 2009. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest 136:1554-1560. http://dx.doi.org/10.1378/chest.09-0132.
4. Henry RL, Mellis CM, Petrovic L. 1992. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr. Pulmonol. 12:158-161. http://dx.doi.org/10.1002/ppul.1950120306.
5. Kerem E, Corey M, Gold R, Levison H. 1990. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J. Pediatr. 116:714-719. http://dx.doi.org/10.1016/ S0022-3476(05)82653-8. (Pubitemid 20162819)
6. Kerem E, Corey M, Stein R, Gold R, Levison H. 1990. Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients. Pediatr. Infect. Dis. J. 9:494-498. http://dx.doi.org/10.1097/00006454-199007000-00008. (Pubitemid 20218406)
7. Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, Green CG, Collins J, Farrell PM. 2001. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr. Pulmonol. 32:277-287. http://dx.doi.org/10.1002/ppul.2009.abs. (Pubitemid 32938876)
8. Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML. 2005. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 293:581-588. http://dx.doi.org/10.1001/jama.293.5.581. (Pubitemid 40171240)
9. Aaron SD, Vandemheen KL, Ramotar K, Giesbrecht-Lewis T, Tullis E, Freitag A, Paterson N, Jackson M, Lougheed MD, Dowson C, Kumar V, Ferris W, Chan F, Doucette S, Fergusson D. 2010. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. JAMA 304:2145-2153. http://dx.doi.org/10.1001/jama.2010.1665.
10. Kidd TJ, Ritchie SR, Ramsay KA, Grimwood K, Bell SC, Rainey PB. 2012. Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. PLoS One 7:e44199. http://dx.doi.org/10.1371/journal.pone.0044199.
11. Schelstraete P, Van Daele S, De Boeck K, Proesmans M, Lebecque P, Leclercq-Foucart J, Malfroot A, Vaneechoutte M, De Baets F. 2008. Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients. Eur. Respir. J. 31:822-829. http://dx.doi.org/10.1183/09031936.00088907.
12. Kelly NM, Fitzgerald MX, Tempany E, O'Boyle C, Falkiner FR, Keane CT. 1982. Does pseudomonas cross-infection occur between cysticfibrosis patients. Lancet ii:688-690. (Pubitemid 12061527)
13. Bradbury R, Champion A, Reid DW. 2008. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population. Respirology 13: 886-892. http://dx.doi.org/10.1111/j.1440-1843.2008.01383.x.
14. Jones AM, Dodd ME, Morris J, Doherty C, Govan JR, Webb AK. 2010. Clinical outcome for cystic fibrosis patients infected with transmissible Pseudomonas aeruginosa: an 8-year prospective study. Chest 137:1405-1409. http://dx.doi.org/10.1378/chest.09-2406.
15. Fothergill JL, Walshaw MJ, Winstanley C. 2012. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur. Respir. J. 40:227-238. http://dx.doi.org/10.1183/09031936.00204411.
16. Clifton IJ, Peckham DG. 2010. Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis. Expert Rev. Respir. Med. 4:519-529. http://dx.doi.org/10.1586/ers.10.42.
17. Cheng K, Smyth RL, Govan JR, Doherty C, Winstanley C, Denning N, Heaf DP, van Saene H, Hart CA. 1996. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 348:639-642. http://dx.doi.org/ 10.1016/S0140-6736(96)05169-0. (Pubitemid 26293808)
18. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Rock MJ, Campbell PW, 3rd. 2008. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J. Pediatr. 153: S4-S14. http://dx.doi.org/10.1016/j.jpeds.2008.05.005. (Pubitemid 351970581)
19. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. 2003. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J. Cyst. Fibros. 2:29-34. http://dx.doi.org/10.1016/S1569- 1993(02)00141-8. (Pubitemid 36857407)
20. Scott FW, Pitt TL. 2004. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J. Med. Microbiol. 53:609-615. http://dx.doi.org/10.1099/jmm. 0.45620-0. (Pubitemid 38932357)
21. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
22. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. 2004. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol. 42:5644-5649. http://dx.doi.org/10.1128/JCM.42. 12.5644-5649.2004. (Pubitemid 39664348)
23. Beaudoin T, Aaron SD, Giesbrecht-Lewis T, Vandemheen K, Mah TF. 2010. Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada. Can. J. Microbiol. 56:548-557. http://dx.doi.org/10.1139/W10-043.
24. Kidd TJ, Grimwood K, Ramsay KA, Rainey PB, Bell SC. 2011. Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis. J. Clin. Microbiol. 49:263-268. http://dx.doi.org/10.1128/JCM.01421-10.
25. Waters V, Zlosnik JE, Yau YC, Speert DP, Aaron SD, Guttman DS. 2012. Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Eur. J. Clin. Microbiol. Infect. Dis. 31:3341-3350. http://dx.doi.org/10.1007/s10096-012-1701-z.
26. CLSI. 2010. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. M100-S19, vol 29, no 31-156. Clinical and Laboratory Standards Institute, Wayne, PA.
27. Parkins MD, Rendall JC, Elborn JS. 2012. Incidence and risk factors for pulmonary exacerbation treatment failures in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa. Chest 141:485-493. http://dx.doi.org/10.1378/chest.11-0917.
28. Armstrong DS, Nixon GM, Carzino R, Bigham A, Carlin JB, Robins-Browne RM, Grimwood K. 2002. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am. J. Respir. Crit. Care Med. 166:983-987. http://dx.doi.org/10.1164/rccm.200204-269OC. (Pubitemid 35193230)
29. Romling U, Kader A, Sriramulu DD, Simm R, Kronvall G. 2005. Worldwide distribution of Pseudomonas aeruginosa clone C strains in the aquatic environment and cystic fibrosis patients. Environ. Microbiol. 7:1029-1038. http://dx.doi.org/10.1111/j.1462-2920.2005.00780.x. (Pubitemid 40817161)
30. Romling U, Wingender J, Muller H, Tummler B. 1994. A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl. Environ. Microbiol. 60:1734-1738. (Pubitemid 24165812)
31. Luna RA, Millecker LA, Webb CR, Mason SK, Whaley EM, Starke JR, Hiatt PW, Versalovic J. 2013. Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain. J. Clin. Microbiol. 51:1237-1240. http://dx.doi.org/10.1128/JCM.02157-12.
32. Speert DP, Campbell ME, Henry DA, Milner R, Taha F, Gravelle A, Davidson AG, Wong LT, Mahenthiralingam E. 2002. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am. J. Respir. Crit. Care Med. 166:988-993. http://dx.doi.org/10.1164/rccm.2203011. (Pubitemid 35193231)
33. Wainwright CE, France MW, O'Rourke P, Anuj S, Kidd TJ, Nissen MD, Sloots TP, Coulter C, Ristovski Z, Hargreaves M, Rose BR, Harbour C, Bell SC, Fennelly KP. 2009. Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis. Thorax 64:926-931. http://dx.doi.org/10.1136/thx.2008.112466.
34. Dinesh SD, Grundmann H, Pitt TL, Romling U. 2003. European-wide distribution of Pseudomonas aeruginosa clone C. Clin. Microbiol. Infect. 9:1228-1233. http://dx.doi.org/10.1111/j.1469-0691.2003.00793.x. (Pubitemid 38028874)
35. Kidd TJ, Ramsay KA, Hu H, Marks GB, Wainwright CE, Bye PT, Elkins MR, Robinson PJ, Rose BR, Wilson JW, Grimwood K, Bell SC. 2013. Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. Eur. Respir. J. 41:1091-1100. http://dx.doi.org/10.1183/09031936.00060512.
36. Hoiby N, Pedersen SS. 1989. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr. Scand. 78: 395-404. http://dx.doi.org/10.1111/j.1651-2227.1989.tb11099.x. (Pubitemid 19133189)
37. Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, Webb AK. 2001. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358:557-558. http://dx.doi.org/10.1016/ S0140-6736(01)05714-2. (Pubitemid 32772734)
38. Pedersen SS, Jensen T, Pressler T, Hoiby N, Rosendal K. 1986. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection? Acta Paediatr. Scand. 75:840-845. http://dx.doi.org/10. 1111/j.1651-2227.1986.tb10299.x. (Pubitemid 16012268)
39. Pedersen SS, Koch C, Hoiby N, Rosendal K. 1986. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J. Antimicrob. Chemother. 17:505-516. http://dx.doi.org/10.1093/jac/17.4.505. (Pubitemid 16143216)
40. Brimicombe RW, Dijkshoorn L, van der Reijden TJ, Kardoes I, Pitt TL, van den Broek PJ, Heijerman HG. 2008. Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J. Cyst. Fibros. 7:30-36. http://dx.doi.org/10.1016/j.jcf.2007.04.002.
41. Pedersen SS, Jensen T, Hoiby N, Koch C, Flensborg EW. 1987. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients. Acta Paediatr. Scand. 76:955-961. http://dx.doi.org/10.1111/j.1651-2227.1987.tb17271. x. (Pubitemid 18059864)
42. Petersen NT, Hoiby N, Mordhorst CH, Lind K, Flensborg EW, Bruun B. 1981. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma - possible synergism with Pseudomonas aeruginosa. Acta Paediatr. Scand. 70:623-628. http://dx.doi.org/10.1111/j.1651-2227.1981.tb05757.x. (Pubitemid 12196513)
43. Conway S. 2008. Segregation is good for patients with cystic fibrosis. J. R. Soc. Med. 101 (Suppl 1): S31-S35. http://dx.doi.org/10.1258/jrsm.2008. s18007.
44. Agarwal G, Kapil A, Kabra SK, Das BK, Dwivedi SN. 2005. Characterization of Pseudomonas aeruginosa isolated from chronically infected children with cystic fibrosis in India. BMC Microbiol. 5:43. http://dx.doi.org/10.1186/1471- 2180-5-43.
45. Leao R, Carvalho-Assef APD, Ferreira AG, Folescu TW, Barth AL, Pitt TL, Marques EA. 2010. Comparison of the worldwide transmissible Pseudomonas aeruginosa with isolates from Brazilian cystic fibrosis patients. Braz. J. Microbiol. 41: 1079-1081. http://dx.doi.org/10.1590/S1517-83822010000400028.
46. Schmid J, Ling LJ, Leung JL, Zhang N, Kolbe J, Wesley AW, Mills GD, Brown PJ, Jones DT, Laing RT, Pattemore PK, Taylor DR, Grimwood K. 2008. Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics. Eur. Respir. J. 32:1583-1590. http://dx.doi.org/10.1183/09031936.00099508.
47. Speert DP. 2002. Molecular epidemiology of Pseudomonas aeruginosa. Front. Biosci. 7:e354-e361. http://dx.doi.org/10.2741/speert.
48. Merlo CA, Boyle MP, Diener-West M, Marshall BC, Goss CH, Lechtzin N. 2007. Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis. Chest 132:562-568. http://dx.doi.org/10.1378/ chest.06-2888. (Pubitemid 47282389)
49. Ashish A, Shaw M, Winstanley C, Ledson MJ, Walshaw MJ. 2012. Increasing resistance of the Liverpool epidemic strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF) - a cause for concern? J. Cyst. Fibros. 11:173-179. http://dx.doi.org/10.1016/j.jcf.2011.11.004.
50. Ashish A, Shaw M, McShane J, Ledson MJ, Walshaw MJ. 2012. Health-related quality of life in cystic fibrosis patients infected with transmissible Pseudomonas aeruginosa strains: cohort study. JRSM Short Rep. 3:12. http://dx.doi.org/10.1258/shorts.2011.011119.
51. Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw MJ, Brockhurst MA, Winstanley C. 2011. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am. J. Respir. Crit. Care Med. 183:1674-1679. http://dx.doi.org/10.1164/rccm.201009-1430OC.
52. Workentine ML, Sibley CD, Glezerson B, Purighalla S, Norgaard-Gron JC, Parkins MD, Rabin HR, Surette MG. 2013. Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS One 8:e60225. http://dx.doi.org/10.1371/journal.pone.0060225.
53. Turton JF, Turton SE, Yearwood L, Yarde S, Kaufmann ME, Pitt TL. 2010. Evaluation of a nine-locus variable-number tandem-repeat scheme for typing of Pseudomonas aeruginosa. Clin. Microbiol. Infect. 16:1111-1116. http://dx.doi.org/10.1111/j.1469-0691.2009.03049.x.
54. Garcia-Castillo M, Maiz L, Morosini MI, Rodriguez-Banos M, Suarez L, Fernandez-Olmos A, Baquero F, Canton R, del Campo R. 2012. Emergence of a mutL mutation causing multilocus sequence typing-pulsed-field gel electrophoresis discrepancy among Pseudomonas aeruginosa isolates from a cystic fibrosis patient. J. Clin. Microbiol. 50:1777-1778. http://dx.doi.org/10.1128/JCM.05478- 11.
55. Aaron SD, Ramotar K, Ferris W, Vandemheen K, Saginur R, Tullis E, Haase D, Kottachchi D, St Denis M, Chan F. 2004. Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med. 169:811-815. http://dx.doi.org/10.1164/rccm.200309-1306OC. (Pubitemid 38402456)